Tumor Supressor Genes Flashcards
Function of Tumor Suppressor Genes
– Transcription factors, cell cycle inhibitors, signal transduction molecules, cell surface receptors, regulators of cellular responses to DNA damage
Gene: APC Protein Function Familial Syndromes Sporadic Cancers
Inhibitors of Mitogenic Signaling Pathways
Gene: APC; 5q21
Protein: Adenomatous polyposis coli protein
Function: Inhibitor of WNT signaling
Familial Syndromes: Familial colonic polyps and carcinomas at very early age
Sporadic Cancers: Carcinomas of stomach, colon, pancreas; melanoma
NF1
Gene: RB Protein Function Familial Syndromes Sporadic Cancers
Inhibitor of Cell Cycle Progression
Gene: RB; 13q14
Protein: Retinoblastoma (RB) protein
Function: Inhibitor of G1/S transition during cell cycle progression
Familial Syndromes: Familial retinoblastoma syndrome (retinoblastoma, osteosarcoma, other sarcomas)
Sporadic Cancers: Retinoblastoma; osteosarcoma carcinomas of breast, colon, lung
Gene: VHL Protein Function Familial Syndromes Sporadic Cancers
Inhibitor of “Pro-growth” Programs of Metabolism and Angiogenesis
Gene: VHL; 3
Protein: Von Hippel Lindau (VHL) protein
Function: Inhibitor of hypoxia-induced transcription factors (e.g., HIF1α)
Familial Syndromes: Von Hippel Lindau syndrome (cerebellar hemangioblastoma, retinal angioma, renal cell carcinoma)
Sporadic Cancers: Renal cell carcinoma
Gene: TP53 Protein Function Familial Syndromes Sporadic Cancers
Enablers of Genomic Stability
Gene: TP53; 17p13.1
Protein: p53
Function: “guardian of the genome;” Cell cycle arrest (permanent =senescence) and apoptosis in response to DNA damage
Familial Syndromes: Li-Fraumeni syndrome (diverse cancers)
Sporadic Cancers: most human cancer (mutated in >50%)
Gene: WT1 Protein Function Familial Syndromes Sporadic Cancers
Unknown Mechanism Gene: WT1; 11p13 Protein: Wilms tumor-1 (WT1) Function: Transcription factor Familial Syndromes: Familial Wilms tumor Sporadic Cancers:  Wilms tumor, certain leukemias
Gene: BRCA1, BRCA2 Protein Function Familial Syndromes Sporadic Cancers
DNA Repair Factors
Gene: Breast cancer-1 and breast cancer-2 (BRCA1 and BRCA2)
Protein: Repair of double- stranded breaks in DNA
Function: Repair of double- stranded breaks in DNA
Familial Syndromes:Familial breast and ovarian carcinoma; carcinomas of male breast; chronic lymphocytic leukemia (BRCA2)
Sporadic Cancers: Rare
WARBURG effect
Deregulation of cellular metabolism in the presence of oncogenes
Glycolysis and cancer
Cancer cells prefer aerobic glycolysis to generate energy and metabolic intermediates; used for rapid growth and cellular components (DNA, RNA, proteins, lipids, organelles
Important types of defects of DNA repair mechanisms
o The mismatch repair “spell checkers” (damage from UV light normally; mismatch bt 2 base)
o The nucleotide excision repair (replace abnormal with normal)
o The recombination repair
hereditary nonpolyposis cancer syndrome (HNPCC)
a condition of familial cancers of the colon (cecum and proximal rectum) results from defects in DNA mismatch repair genes (the genome “spell checkers”)
xeroderma pigmentosum
xeroderma pigmentosum, a condition prone to the development of skin cancer, results from defects of the nucleotide excision repair (NER) pathway
ataxia-telangiectasia syndrome
autosomal recessive disorder telangiectasia syndrome caused by a mutation of the ATM gene; results from defects in DNA repair by homologous recombination
Tumor progression and heterogeneity
tumors are monoclonal
when clinically evident they are extremely heterogeneous in regards to
- invasiveness,
- rate of growth,
- metastatic ability,
- hormonal responsiveness
- susceptibility to antineoplastic drugs.
tumor consists of many subclones with different characteristics.
Subclones best adept:
-survival, growth, invasion and metastasis.
Process of invasion of tumor cell into extracellular matrix
o Detachment of tumor cells from each other
o Attachment to matrix components
o Degradation of ECM
o Migration of tumor cells
two hit hypothesis
In hereditary cases the first genetic change (“first hit”) is inherited from an affected parent.
The second mutation (“second hit”) happens subsequently in one of the cells that already carries the first mutation.